This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
World Liver Day 2025 | A Global Call to Action for Liver Health through Nutrition A global coalition of leading health organizations unites to mark World Liver Day on Saturday, April 19, emphasizing the pivotal role of nutrition in supporting liver function and preventing disease.
18, 2025 About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, kidney disease, type 2 diabetes and obesity.[1] DALLAS, Feb. 1] This cluster of chronic health conditions is called.
On-demand access is available now and will remain open until December 2025. Obesity: Learn about behavioral approaches, the latest in pharmacotherapy, and surgical interventions for managing obesity. When Will It Be Available? Make sure to mark your calendar so you can take full advantage of this extensive resource!
Stroke, Volume 56, Issue Suppl_1 , Page A51-A51, February 1, 2025. Background:Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown a reduction in major adverse cardiovascular events (MACE) among patients with type 2 diabetes mellitus (T2DM). 1.00),P=0.05), hemorrhagic stroke (OR, 0.82(95%CI:
Stroke, Volume 56, Issue Suppl_1 , Page ATP268-ATP268, February 1, 2025. Older adults with obesity and metabolic syndrome may have decreased elimination of the xylitol metabolite xylose, which may explain the higher observed risk of thrombosis and stroke in older adults who consume foods with sugar alcohols.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP106-AWMP106, February 1, 2025. We further examined interactions between UACR and covariates including age, obesity, white vs other races, and education. However, the interaction term for obesity warranted a stratified analysis (p=0.08). 2.38, p=0.003). 2.38, p=0.003). 2.84, p=0.001).Conclusion:Increased
They had lower risks of hypertension, diabetes, dementia, stroke, Parkinson’s disease, obesity, sleep apnea, and other chronic health conditions compared to inactive adults and similar risks compared to adults accruing their weekly exercise in a greater number of days. 2025 Feb;35(2):e70024. Scand J Med Sci Sports.
Aronne, MD , discussed advances in obesity pharmacology, while Virend K. Florez, MD, PhD , explored the future of precision medicine in diabetes. The 20th Annual CMHC, an anniversary celebration, is already on the horizon, set for October 23-25, 2025, in Boston. Experts like Louis J. Learn more now!
Stroke, Volume 56, Issue Suppl_1 , Page AWP141-AWP141, February 1, 2025. In unadjusted analysis, factors significantly associated with troponin testing were a triage complaint of chest pain, older age, higher mean systolic BP, hypertension, diabetes, obesity, stroke or TIA, congestive heart failure, or coronary disease.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP94-AWMP94, February 1, 2025. vs 7.9%), diabetes (33.6% vs 4.6%), obesity (26.4% This study investigated patient co-morbidity trends to determine if these factors have led to better national patient outcomes.Methods:We performed a data search from the U.S.
Stroke, Volume 56, Issue Suppl_1 , Page ATP319-ATP319, February 1, 2025. Nearly half (47%) of graded census tracts had persistent discrimination and tracts with persistent discrimination were younger, less non-Hispanic white, and had higher proportions of diabetes, obesity and hypertension (Table).
tim.hodson Tue, 04/22/2025 - 09:55 April 22, 2025 Research teams from Augusta University, Massachusetts General Hospital and The Ohio State University will lead a $15 million project dedicated to studying the various ways that risk factors for cardiovascular and kidney diseases impact women.
tim.hodson Wed, 03/26/2025 - 14:25 March 17, 2025 Bayer recently announcedthat the U.S. 2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). Accessed February 21, 2025. Accessed March 5, 2025. Accessed February 21, 2025. J Card Fail.
Lilly’s blockbuster GLP-1 tirzepatide appears poised to become the next major HFpEF drug, after topline results from the SUMMIT trial showed that it significantly improved both outcomes and symptoms among patients with heart failure with preserved ejection fraction and obesity.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP107-ATMP107, February 1, 2025. 2.12), diabetes (1.41, 95% CI: 1.00-1.98), 1.61), and obesity (OR: 1.51, 95% CI: 0.79-1.20) There was effect modification by race: midlife diabetes was associated with LLD in White individuals (OR: 2.18, 95% CI: 1.42-3.25) At midlife, 20.2%
Stroke, Volume 56, Issue Suppl_1 , Page ATP309-ATP309, February 1, 2025. The prevalence odds of common stroke risk factors including hypertension, diabetes, and overweight/obesity were higher for NHB vs NHW subgroups (e.g., 1.96] for diabetes, 1.24 [1.20-1.28] 1.28] for overweight/obesity; NHB men 18-44 y OR 2.33 [2.26-2.40]
Stroke, Volume 56, Issue Suppl_1 , Page ATP301-ATP301, February 1, 2025. CADASIL patients had lower rates of hypertension, diabetes, and coronary artery disease (55.0% vs 49.8%, p=0.31), obesity (15.0% AIS patients with CADASIL were similar in sex and more likely to be younger (55.8 years, p<0.001), White (70.0%
Stroke, Volume 56, Issue Suppl_1 , Page AWP310-AWP310, February 1, 2025. Smoking, diabetes, hypertension, obesity, Black race, age, low education, male sex, and APOEe4 were associated with an increased risk of dementia/no PD.
SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity. AHA announced a $12M investment in AI research, with an RFP slated for early 2025. Get the latest knowledge and practical tools in cardiometabolic health to improve your practice in 2025.
With an ever-growing incidence of obesity, diabetes and cardiovascular disease, compounded by overwhelmed health services, this principle remains central to healthcare policies today. Diabetes has long been. Introduction In 1736, Benjamin Franklin declared that an ounce of prevention is worth a pound of cure.
Diabetes and Obesity Care Advancements New Technologies for Diabetes Management : The recent FDA approvals of various insulin delivery devices, including the Embecta patch pump for Type 2 diabetes , have expanded patient options. New developments in continuous glucose monitors (CGMs) have also been transformative.
Welcome to 2025 and best wishes for a great academic journey to all readers. 24 and TCT 2024) Colchicine in AMI CLEAR SYNERGY (OASIS 9) (TCT 2024 and AHA 2024) Semaglutide Treatment Effect in People With Obesity and HFpEF and Diabetes Mellitus STEP-HFpEF DM (ACC.24) Thanks to ACC for compiling it.
42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S., SELECT Trial Results : Semaglutide 2.4
This signature effort for the World Health Organization (WHO) in 2025 will include working with governments, donors, and the health community to invest in proven, high-impact interventions to improve maternal and newborn health and survival. Healthy beginnings, hopeful futures is the theme for World Health Day, Monday, April 7.
Previous research indicates the rate ofischemic(clot-caused) stroke among adults 18-49 years old is increasing and propelled by a corresponding rise incryptogenicstrokes (strokes of unknown cause) in adults without traditional risk factors, including high blood pressure, smoking, obesity, high cholesterol andType 2 diabetes.
In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content